Hot Pursuit     13-Jun-22
Gland Pharma Ltd down for fifth straight session
Gland Pharma Ltd is quoting at Rs 2730, down 1.9% on the day as on 13:19 IST on the NSE. The stock tumbled 24.08% in last one year as compared to a 0.28% slide in NIFTY and a 15.39% fall in the Nifty Metal index.

Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2730, down 1.9% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 2.68% on the day, quoting at 15767.25. The Sensex is at 52834.46, down 2.71%.Gland Pharma Ltd has lost around 12.19% in last one month.Meanwhile, Nifty Metal index of which Gland Pharma Ltd is a constituent, has eased around 3.03% in last one month and is currently quoting at 12419.2, down 1.56% on the day. The volume in the stock stood at 99499 shares today, compared to the daily average of 1.58 lakh shares in last one month.

The PE of the stock is 37.81 based on TTM earnings ending March 22.

Previous News
  Indices trade higher; PSU bank shares advance
 ( Market Commentary - Mid-Session 29-Apr-24   14:34 )
  Gland Pharma appoints Chief Operating Officer
 ( Corporate News - 29-Apr-24   14:51 )
  Gland Pharma gets US FDA nod for Cetrorelix Acetate
 ( Hot Pursuit - 29-Apr-24   13:23 )
  Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
 ( Corporate News - 06-Apr-24   17:40 )
  Gland Pharma consolidated net profit declines 17.28% in the December 2023 quarter
 ( Results - Announcements 14-Feb-24   17:22 )
  Gland Pharma to table results
 ( Corporate News - 09-May-24   14:47 )
  Volumes soar at Gland Pharma Ltd counter
 ( Hot Pursuit - 19-Jun-24   11:00 )
  Gland Pharma gets tentative nod from US FDA for hypotension treatment drug
 ( Hot Pursuit - 15-Nov-23   12:14 )
  Gland Pharma receives USFDA tentative approval for Angiotensin II Injection
 ( Corporate News - 15-Nov-23   11:42 )
  US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
 ( Hot Pursuit - 05-Aug-24   12:19 )
  Gland Pharma's Pashamylaram facility clears USFDA inspection
 ( Corporate News - 26-Sep-23   11:46 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top